York PhD project P21: Sustainable diversification of therapeutic peptides via amino-carbonylation

York PhD project P21: Sustainable diversification of therapeutic peptides via amino-carbonylation

Decision Summary

Can fully synthesised, deprotected therapeutic peptides be diversified with fewer repeated steps and less solvent while retaining useful selectivity and function? P21 approaches that question through late-stage transition-metal chemistry, side-chain modification and peptide stapling. The CSHP research-project list identifies the 2027-entry project at York, supervised by Christopher Spicer, Ian Fairlamb and Molly Stevens, with Johnson & Johnson Innovative Medicine as industrial partner.

The scientific case is unusually concrete because the team has already published a directly relevant 2026 paper on mild carbonylative late-stage modification of unprotected peptides. Important decisions concern both applicability of the chemistry and financial terms: a China-based applicant can apply, but public funding materials do not guarantee that every international award will cover the full overseas-fee difference. Written confirmation is required before treating the offer as fully funded.

Reaction applicability and downstream biological relevance still require project-specific testing; the funding letter must establish the individual international award.

Doctoral Work and Application

The advertised work develops late-stage strategies for side-chain modification and peptide stapling, using the team’s peptide/protein and transition-metal expertise. Functional-group tolerance, site control, isolation and retention of useful biomolecular properties are research questions, not already-solved capabilities. The advertised target sequence, catalyst and exact validation design remain open.

The recruitment asks for an online York Chemistry PhD application, a 1,000-word personal statement ending with 1–2–3 ranked project choices, university transcripts and two academic/professional referee contacts; York applicants also complete the CSHP EDI form. The first-round deadline is 13 November 2026 at 12 noon; the time zone needs confirmation. Later submissions may be considered, but a preferred project can already be allocated. Project contact: chris.spicer@york.ac.uk; general enquiries: cshp-cdt@chem.ox.ac.uk or chem-env-pgr@york.ac.uk.

School, Programme and Training

The CSHP CDT is a four-year Oxford-York programme with cohort training followed by a substantive research project. The official application page says up to sixteen fully funded places are available annually across the partnership and requires applicants to rank preferred projects. The CSHP FAQs show that assessment weighs academic record, references, and motivation/fit equally, followed by a technical interview and project-allocation process.

York is a credible host for this topic. The University's REF 2021 summary reports Chemistry in the UK top ten in the REF-based Times Higher Education analysis, with most research and impact rated world-leading. The Green Chemistry Centre of Excellence provides an established sustainability setting and industrial-engagement model. Its facilities page lists NMR, HPLC, GC, mass spectrometry, X-ray methods, thermal analysis and specialist reactors. The general York Chemistry PhD page supports the broader doctoral environment, but project-specific instrument time and assay access should still be confirmed.

Supervisor and Lab Assessment

Christopher Spicer works on peptide/protein chemistry, bioconjugation and biomolecule-material interfaces. Ian Fairlamb brings transition-metal catalysis, carbonyl chemistry, mechanism-driven synthesis and automated reaction screening. Molly Stevens adds advanced therapeutics, biomaterials, interdisciplinary translation and commercialisation experience.

The combination is compelling: Spicer covers peptide and protein modification, Fairlamb covers catalysis and carbonylation, and Stevens strengthens therapeutic and translational framing. The remaining issue is operational. The project is based mainly at York, so candidates should ask who supervises daily work, how frequently the Oxford supervisor is involved, and what the J&J partner contributes in data, compounds, assays, facilities or placement time.

Recent Publications and Scientific Fit

The strongest foundation is the 2026 Chemical Science paper, Peptide modification via a mild carbonylative Suzuki-Miyaura reaction gives late-stage access to diaryl-ketones. It demonstrates an operationally simple reaction under mild aqueous conditions on unprotected peptides using a carbon-monoxide surrogate. This maps directly to the advertised amino-carbonylation direction. The next challenge is broader substrate scope, residue selectivity, metal removal, stapling and biological validation.

The 2025 JACS Au paper, Effect of Pyridinecarboxaldehyde Functionalization on Reactivity and N-Terminal Protein Modification, shows the Spicer group using mechanistic understanding to improve protein-labeling reagents. It is not the same reaction class, but it supports the laboratory's ability to connect reaction design with biomolecule performance.

The earlier Palladium-Mediated Cell-Surface Labeling paper is foundational evidence that metal-mediated bond formation can be made compatible with living biological surfaces. It is older and should not be overread as proof that P21 will automatically work on therapeutic peptides, but it shows a long-running research trajectory rather than an opportunistic topic.

Research Direction and Field Outlook

Late-stage diversification can reduce the need to rebuild a peptide from the beginning for every analogue. If robust, it could generate side-chain variants or stapled peptides in fewer steps and with less solvent and protecting-group use. The most valuable thesis would deliver not only a few successful examples but also design rules: which residues tolerate the reaction, which catalysts and carbonyl sources work, how metal residues are controlled, and whether modified peptides retain useful structure and activity.

Career Directions

The field has good career relevance. The UK Life Sciences Jobs Plan anticipates substantial additional demand in life-science occupations through 2035. The Royal Society of Chemistry's workforce analysis reports above-average projected growth for chemical-science roles and particularly strong demand for sustainability and green skills. These signals support careers in medicinal chemistry, peptide therapeutics, chemical biology, process chemistry and pharmaceutical R&D, but do not guarantee a specific job.

Funding and Cost Risk for International Applicants

Funding needs precise confirmation. EPSRC CDT rules apply a standard cap on international students and limit training-grant fee support to the Home-fee level. The programme's international funding FAQ says international students may receive full funding within UKRI limits, but recommends considering additional scholarship cover for the fee difference. York's international research-fee page shows why this matters: overseas Chemistry PhD fees are materially higher than the Home rate.

A Chinese applicant is not barred from applying. The correct interpretation is that eligibility exists, but the number of funded international places is limited and the fee-gap mechanism must be checked. Ask the CDT and York for written confirmation covering tuition, stipend, annual uplift and research costs. For day-to-day planning, use York's living-cost guidance and allow for inflation, visa and health-surcharge costs.

Applicant Fit and Preparation

The advert requires an obtained or expected minimum UK 2:1 Honours degree or international equivalent in a relevant subject, usually chemistry or chemical engineering; other relevant qualifications can be discussed with the team. Research enthusiasm, independent thinking and work, excellent analytical skills, and strong spoken and written communication are essential. The techniques listed below are examples of useful evidence, rather than additional mandatory entry requirements.

Best fit backgrounds include synthetic chemistry, organic chemistry, chemical biology, medicinal chemistry and peptide/protein chemistry. Strong evidence might include peptide synthesis, transition-metal catalysis, cross-coupling, reaction optimisation, LC-MS/HPLC, NMR, protein labeling, assay work or mechanistic analysis.

The application should explain why late-stage peptide modification is valuable, identify one or two technical bottlenecks, and connect prior work to those bottlenecks. Because project allocation is competitive, the candidate should also be ready to discuss alternative ranked projects while showing a clear reason for preferring P21.

Risks and Questions to Verify

1. Will the 2027 York studentship pay the full overseas tuition fee for a China-based applicant, or only the Home-rate amount?
2. How many international awards are available at York, and how is the UKRI cap applied across the partnership?
3. What stipend, annual uplift and research-cost budget apply?
4. Who provides daily supervision, and how often will the Oxford and J&J supervisors meet the student?
5. Is there a mandatory J&J placement, and what IP, confidentiality and publication-review rules apply?
6. Which peptide sequences, catalysts, analytical platforms and biological assays are already committed?
7. What first-year milestones decide whether the work advances from reaction discovery to therapeutic validation?
8. Which skills are required on entry and which are taught through the CDT?

Evidence and Sources

The 2026 and 2025 papers and the 2012 foundational study play distinct roles in the project rationale. The chemistry and funding claims above remain limited to the cited evidence; an offer must state the international tuition arrangement for the actual award years.

• Official P21 project list
• How to apply
• Admissions FAQs
• Oxford course overview for the joint CDT
• EPSRC CDT funding rules
• CSHP international funding FAQ
• Christopher Spicer
• Ian Fairlamb
• Molly Stevens
• Carbonylative peptide modification paper
• N-terminal protein modification paper
• Palladium-mediated cell-surface labeling
• GCCE facilities
• GCCE overview
• York REF results
• York Chemistry PhD
• York international research fees
• York living costs
• UK Life Sciences Jobs Plan
• RSC workforce analysis